ReviewOncology reviews2026
Breast cancer in immigrant women in Europe and Italy: epidemiology, disparities, and pathways to equity.
Review in Oncology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immigrant women in Europe and Italy represent a growing and heterogeneous population whose breast cancer (BC) experience is influenced by social, cultural, and healthcare system factors. Although first-generation immigrants generally have a lower BC incidence, risk converges over time with that of native populations, while barriers to care persist. To analyze disparities in BC screening, diagnosis, tumour characteristics, treatment pathways, and outcomes among immigrant women in Europe and Italy, and to identify strategies to promote equity. A narrative review of European and Italian literature was conducted, focusing on screening uptake, stage at diagnosis, tumour biology, access to diagnostics and treatments, and outcomes. Social determinants of health and healthcare system barriers were also considered. Screening participation is consistently lower among immigrant women because of a combination of language barriers, limited knowledge of screening programmes, limited culturally shaped beliefs, about health and cancer, competing work and caregiving responsibilities, and practical obstacles such as transportation and appointment scheduling, leading to delayed diagnosis and more advanced disease. Socioeconomic disadvantage and residence in underserved areas further limit access to diagnostic procedures, treatment, and follow-up. Potential differences in tumour biology have been reported, but data are limited and rarely stratified by region of origin. Disparities also affect treatment pathways, with delays and unequal access to advanced technologies. Long-term outcomes remain poorly documented. Reducing disparities requires coordinated policy and health system interventions, including standardized migration data collection, equitable access to screening and treatment, inclusion in clinical research, and culturally tailored education and patient-navigation programs. Equity should be central to BC care in Europe and Italy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.